Main public logs
Jump to navigation
Jump to search
Combined display of all available logs of wikidoc. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
- 14:40, 16 May 2024 Alen Antony talk contribs created page Leniolisib (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=leniolisib |aOrAn=a |drugClass=kinase inhibitor |indicationType=treatment |indication=activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) in adult and pediatric patients 12 years of age and older. |adverseReactions=headache, sinusitis, and {{atopic dermatitis}}. |brandNames=JOENJA }}")
- 10:11, 16 May 2024 Muhammad Waleed talk contribs created page Avacincaptad pegol (Created page with "{{DrugProjectFormSinglePage |genericName=Avacincaptad Pegol |drugClass=Avacincaptad pegol is a complement C5 protein inhibitor |indication=IZERVAY is indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). |adverseReactions=Common adverse reactions (≥5% of patients) include conjunctival hemorrhage, increased intraocular pressure, and endophthalmitis. |blackBoxWarningTitle=There is no black box warning listed for IZERV...")
- 09:31, 16 May 2024 Muhammad Waleed talk contribs created page File:Talvey (talquetamab-tgvs).png (image for the drug Talvey)
- 09:31, 16 May 2024 Muhammad Waleed talk contribs uploaded File:Talvey (talquetamab-tgvs).png (image for the drug Talvey)
- 07:06, 16 May 2024 Alara E. Dagsali talk contribs created page Diclofenac Patch (Created page with "{{DrugProjectFormSinglePage |authorTag=Alara E.Dagsali |OTC=Yes |genericName=DICLOVIX |indicationType=treatment |indication=Diclofenac sodium topical solution is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of signs and symptoms of osteoarthritis of the knee(s). |hasBlackBoxWarning=Yes |adverseReactions=Dry Skin (Application Site) Contact Dermatitis (Application Site) Dyspepsia Abdominal Pain Flatulence Pruritus (Application Site) Diarr...")
- 06:42, 16 May 2024 Alara E. Dagsali talk contribs created page Cortisone Acetate (Created page with "{{DrugProjectFormSinglePage |authorTag=Alara E.Dagsali |OTC=Yes |genericName=Cortisone Acetate |aOrAn=a |indicationType=treatment |indication=When oral therapy is not feasible: 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). Congen...")
- 06:32, 16 May 2024 Alara E. Dagsali talk contribs created page Clocortolone Pivalate (Created page with "{{DrugProjectFormSinglePage |authorTag=Alara E.Dagsali |genericName=Clocortolone Pivalate |indicationType=treatment |indication=Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. |adverseReactions=The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed...")
- 06:20, 16 May 2024 Alara E. Dagsali talk contribs created page Scorpion (Created page with "{{DrugProjectFormSinglePage |genericName=Anascorp |indicationType=treatment |indication=ANASCORP® [centruroides (scorpion) immune F(ab')2 (equine) injection] is an equine-derived antivenom indicated for treatment of patients with clinical signs of scorpion envenomation. |adverseReactions=The most common adverse reactions observed in ≥ 2% of patients in the clinical studies for ANASCORP were: vomiting, pyrexia, rash, nausea and pruritus. |fdaLIADAdult=For Intravenous u...")
- 10:58, 15 May 2024 Alara E. Dagsali talk contribs created page Lodoxamide (Created page with "{{DrugProjectFormSinglePage |authorTag=Alara E.Dagsali |genericName=Alomide |indicationType=treatment |indication=ALOMIDE® (lodoxamide tromethamine ophthalmic solution) 0.1% is indicated in the treatment of the ocular disorders referred to by the terms vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis. |adverseReactions=During clinical studies of ALOMIDE® (lodoxamide tromethamine ophthalmic solution) 0.1%, the most frequently reported ocular adve...")
- 23:48, 13 May 2024 Alen Antony talk contribs created page Fezolinetant (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |OTC=Yes |genericName=fezolinetant }}")
- 20:38, 13 May 2024 Muhammad Waleed talk contribs created page Talquetamab-tgvs (Created page with "{{DrugProjectFormSinglePage |authorTag=Muhammad Waleed, M.B.B.S. [mailto:muhammad_waleed@ymail.com] |genericName=Talquetamab-tgvs |aOrAn=a |drugClass=bispecific GPRC5D-directed CD3 T-cell engager |indicationType=treatment |indication=TALVEY is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent...")
- 14:50, 13 May 2024 Alen Antony talk contribs created page Nirsevimab-alip (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=Nirsevimab-alip |aOrAn=a |drugClass=human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody |indicationType=prevention |indication=Respiratory Syncytial Virus (RSV) lower respiratory tract disease for neonates and infants born during or entering their first RSV season and children up to 24 years of age who are vulnerable to severe RSV disease in their second RSV season. |adverseReactions=rashes and injection...")
- 19:35, 12 May 2024 Kosar Doraghi talk contribs created page File:IMG 1208.jpeg
- 19:35, 12 May 2024 Kosar Doraghi talk contribs uploaded File:IMG 1208.jpeg
- 19:33, 12 May 2024 Kosar Doraghi talk contribs created page File:IMG 1207.jpeg
- 19:33, 12 May 2024 Kosar Doraghi talk contribs uploaded File:IMG 1207.jpeg
- 19:32, 12 May 2024 Kosar Doraghi talk contribs created page File:IMG 1204.jpeg
- 19:32, 12 May 2024 Kosar Doraghi talk contribs uploaded File:IMG 1204.jpeg
- 19:30, 12 May 2024 Kosar Doraghi talk contribs created page File:IMG 1202.jpeg
- 19:30, 12 May 2024 Kosar Doraghi talk contribs uploaded File:IMG 1202.jpeg
- 19:28, 12 May 2024 Kosar Doraghi talk contribs created page File:IMG 1200.jpeg
- 19:28, 12 May 2024 Kosar Doraghi talk contribs uploaded File:IMG 1200.jpeg
- 19:24, 12 May 2024 Kosar Doraghi talk contribs created page File:IMG 1214.jpeg
- 19:24, 12 May 2024 Kosar Doraghi talk contribs uploaded File:IMG 1214.jpeg
- 05:30, 12 May 2024 Kosar Doraghi talk contribs created page Somatrogon-ghla (Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.con] |genericName=somatrogon-ghla |aOrAn=a |drugClass=human growth hormone analog |indicationType=treatment |indication=pediatric patients aged 3 years and older who have growth failure due to inadequate secretion of endogenous growth hormone |hasBlackBoxWarning=Yes |adverseReactions=injection site reactions, nasopharyngitis, headache, pyrexia, anemia, cough, v...")
- 05:15, 12 May 2024 Kosar Doraghi talk contribs created page File:IMG 1198.jpeg
- 05:15, 12 May 2024 Kosar Doraghi talk contribs uploaded File:IMG 1198.jpeg
- 05:13, 12 May 2024 Kosar Doraghi talk contribs created page File:IMG 1215.jpeg
- 05:13, 12 May 2024 Kosar Doraghi talk contribs uploaded File:IMG 1215.jpeg
- 20:21, 11 May 2024 Rithish Nimmagadda talk contribs created page Elfabrio (Created page with "{{DrugProjectFormSinglePage |authorTag={{VSRN}} |genericName=Pegunigalsidase Alfa-iwxj |drugClass=a hydrolytic lysosomal neutral glycosphingolipid-specific enzyme, is a pegylated recombinant form of human α-galactosidase A |indicationType=treatment |indication=ELFABRIO is an FDA approved drug that is used for treatment of adults with confirmed Fabry disease. |hasBlackBoxWarning=Yes |adverseReactions=Most common adverse reactions (≥15%) are infusion-associated reactio...")
- 19:36, 11 May 2024 Rithish Nimmagadda talk contribs created page Exxua (Created page with "{{DrugProjectFormSinglePage |authorTag={{ }}")
- 13:10, 9 May 2024 Rithish Nimmagadda talk contribs created page Epcoritamab-bysp (Created page with "{{DrugProjectFormSinglePage |authorTag=VSRN }}")
- 10:37, 9 May 2024 Hafiza Amna Qadeer talk contribs created page FUTIBATINIB (Created page with "{{DrugProjectFormSinglePage |authorTag=HAFIZA AMNA QADEER, MD |OTC=Yes |genericName=FUTIBATINIB |aOrAn=a |drugClass=Kinase Inhibitor |indicationType=treatment |indication=* of adult patients with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring fibroblast growth factor receptor 2 (FGFR2) gene fusions or other rearrangements. |adverseReactions=1* Nail Toxicity, stomatitis, dry skin, dry eye, alopecia 2* Musculos...")
- 04:57, 9 May 2024 Alen Antony talk contribs created page Sotagliflozin (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=sotagliflozin |aOrAn=a |drugClass=sodium-glucose co-transporter 2 (SGLT2) inhibitor |indicationType=prophylaxis |indication=heart failure in patients with risk of heart failure, type 2 diabetes mellitus, chronic kidney disease, and other cardiovascular risk factors. |adverseReactions=urinary tract infection, volume depletion, diarrhea, and hypoglycemia. }}")
- 21:32, 8 May 2024 Kosar Doraghi talk contribs created page EXXUA (Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.com] |genericName=Gepirone |aOrAn=a |drugClass=extended-release tablets |indicationType=treatment |indication=major depressive disorder (MDD) in adults |hasBlackBoxWarning=Yes |adverseReactions=dizziness, nausea, insomnia, abdominal pain, and dyspepsia |blackBoxWarningTitle=WARNING: SUICIDAL THOUGHTS AND BEHAVIORS |blackBoxWarningBody=SEE FULL PRESCRIBING INFORMATION FOR...")
- 21:27, 8 May 2024 Kosar Doraghi talk contribs created page File:IMG 1195.jpeg
- 21:27, 8 May 2024 Kosar Doraghi talk contribs uploaded File:IMG 1195.jpeg
- 21:26, 8 May 2024 Kosar Doraghi talk contribs created page File:IMG 1196.jpeg
- 21:26, 8 May 2024 Kosar Doraghi talk contribs uploaded File:IMG 1196.jpeg
- 21:19, 8 May 2024 Kosar Doraghi talk contribs created page File:IMG 1194.jpeg
- 21:19, 8 May 2024 Kosar Doraghi talk contribs uploaded File:IMG 1194.jpeg
- 17:11, 8 May 2024 Imam Ali Shah talk contribs created page File:Screenshot (245).jpg
- 17:11, 8 May 2024 Imam Ali Shah talk contribs uploaded File:Screenshot (245).jpg
- 17:02, 8 May 2024 Imam Ali Shah talk contribs created page File:RCR logo.png
- 17:02, 8 May 2024 Imam Ali Shah talk contribs uploaded File:RCR logo.png
- 16:30, 8 May 2024 Imam Ali Shah talk contribs uploaded a new version of File:Pre-contrast CT scan of the abdomen and pelvis in Cryptogenic Cirrhosis.jpg (Pre-contrast CT scan of the abdomen and pelvis depicts an irregular nodular margin of the liver (green arrowhead), hypertrophy of the caudate lobe (orange arrow), and the presence of ascites (red arrow).)
- 16:21, 8 May 2024 Imam Ali Shah talk contribs created page File:Portal-venous phase CT scan of the abdomen and pelvis in Liver Cirrhosis.png
- 16:21, 8 May 2024 Imam Ali Shah talk contribs uploaded File:Portal-venous phase CT scan of the abdomen and pelvis in Liver Cirrhosis.png
- 16:19, 8 May 2024 Imam Ali Shah talk contribs created page File:Portal-venous phase CT scan of the abdomen and pelvis in Cryptogenic Cirrhosis.jpg
- 16:19, 8 May 2024 Imam Ali Shah talk contribs uploaded File:Portal-venous phase CT scan of the abdomen and pelvis in Cryptogenic Cirrhosis.jpg
.png){kind=link}
.jpg){kind=link}
